Regenerons

EMA backs Regeneron’s lymphoma treatment odronextamab By Investing.com

TARRYTOWN, N.Y. – Regeneron (NASDAQ:) Pharmaceuticals, Inc. (NASDAQ: REGN) has received a positive opinion from the European Medicines Agency’s Committee…